Pneumococcal conjugate second or third-dose vaccines (PCVc) in Colombia

Colombia: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 89.0% in 2025. ▲ Rising

Latest (2025)
89.0%
Change on year
down 2.2%
World rank
72nd
of 194 countries
All-time high
94.0%
in 2018
All-time low
0.0%
in 2008
Years of data
18
2008–2025

Pneumococcal conjugate second or third-dose vaccines (PCVc) in Colombia, 2008–2025

0204060801002008201620252008: 02009: 02010: 222011: 462012: 842013: 872014: 892015: 912016: 892017: 912018: 942019: 932020: 892021: 842022: 852023: 902024: 912025: 89

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Colombia is 89.0%, measured in 2025.

Compared with earlier readings it is down 2.2% on the previous year and down 2.2% over ten years.

Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Colombia peaked at 94.0% in 2018 and was at its lowest, 0.0%, in 2008.

That places Colombia 72nd out of 194 countries with data for 2025, putting it in the middle of the range.

The long-run direction has been consistently rising across the 18 years of available data.

Pneumococcal conjugate second or third-dose vaccines (PCVc) in Colombia, year by year

Annual values for Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC) in Colombia, 2008 to 2025.
Year Value Change
2008 0.0% —
2009 0.0% —
2010 22.0% —
2011 46.0% +109.1%
2012 84.0% +82.6%
2013 87.0% +3.6%
2014 89.0% +2.3%
2015 91.0% +2.2%
2016 89.0% -2.2%
2017 91.0% +2.2%
2018 94.0% +3.3%
2019 93.0% -1.1%
2020 89.0% -4.3%
2021 84.0% -5.6%
2022 85.0% +1.2%
2023 90.0% +5.9%
2024 91.0% +1.1%
2025 89.0% -2.2%

Colombia compared with similar countries

  • Colombia's 89.0% is above the median for upper middle income countries, which is 76.0%, 1.2× the median. (57 countries reporting)
  • Colombia's 89.0% is above the median for Latin America & Caribbean, which is 82.5%, 1.1× the median. (32 countries reporting)

Biggest year-on-year movements

Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Colombia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2011 +109.1% 22.0% 46.0%
2012 +82.6% 46.0% 84.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.0% 0.0% 0.0% 2
2010s 78.6% 22.0% 94.0% 10
2020s 88.0% 84.0% 91.0% 6

Countries ranked near Colombia

  1. 70 Eswatini 90.0% compare
  2. 70 Guinea-Bissau 90.0% compare
  3. 72 New Zealand 89.0% compare
  4. 72 Spain 89.0% compare
  5. 72 United Kingdom 89.0% compare
  6. 72 Togo 89.0% compare
  7. 72 Poland 89.0% compare
  8. 72 Samoa 89.0% compare
  9. 72 Greece 89.0% compare
  10. 72 Croatia 89.0% compare

See the full ranking of 207 places →

More health data for Colombia

All data for Colombia →

Frequently asked questions

What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Colombia?
Pneumococcal conjugate second or third-dose vaccines (pcvc) in Colombia was 89.0% in 2025, according to World Health Organization, Global Health Observatory.
What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Colombia?
The highest recorded value was 94.0% in 2018.
What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Colombia?
The lowest recorded value was 0.0% in 2008.
How does Colombia rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
Colombia ranks 72nd out of 194 countries with data for 2025.
Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Colombia?
Over the last ten years it is down 2.2%. The long-run trend across the full record is rising.
Where does this Colombia data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Pneumococcal conjugate second or third-dose vaccines (PCVc) in Colombia. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 26 September 2026, from https://health.statizoid.com/stat/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/colombia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/colombia/">Pneumococcal conjugate second or third-dose vaccines (PCVc) in Colombia</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
207 places, 3,723 data points, 2008–2025
Last refreshed